These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19928580)

  • 1. [On the possibility of patient phenotyping on the basis of cytochrome p-450 1A2 isoenzyme activity using caffeine as the test substrate].
    Filimonova AA; Ziganshina LE; Ziganshin AU; Chichirov AA
    Eksp Klin Farmakol; 2009; 72(5):61-5. PubMed ID: 19928580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.
    Härtter S; Ursing C; Morita S; Tybring G; von Bahr C; Christensen M; Röjdmark S; Bertilsson L
    Clin Pharmacol Ther; 2001 Jul; 70(1):10-6. PubMed ID: 11452239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets.
    Lampe JW; King IB; Li S; Grate MT; Barale KV; Chen C; Feng Z; Potter JD
    Carcinogenesis; 2000 Jun; 21(6):1157-62. PubMed ID: 10837004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
    Faber MS; Jetter A; Fuhr U
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
    De Kesel PM; Lambert WE; Stove CP
    Clin Pharmacokinet; 2015 Jul; 54(7):771-81. PubMed ID: 25603821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
    Koch JP; ten Tusscher GW; Koppe JG; Guchelaar HJ
    Biomed Chromatogr; 1999 Jun; 13(4):309-14. PubMed ID: 10416066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.
    Härtter S; Korhonen T; Lundgren S; Rane A; Tolonen A; Turpeinen M; Laine K
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):300-4. PubMed ID: 17040215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.
    Tan EK; Chua E; Fook-Chong SM; Teo YY; Yuen Y; Tan L; Zhao Y
    Pharmacogenet Genomics; 2007 Nov; 17(11):1001-5. PubMed ID: 18075470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.
    Shirley KL; Hon YY; Penzak SR; Lam YW; Spratlin V; Jann MW
    Neuropsychopharmacology; 2003 May; 28(5):961-6. PubMed ID: 12644842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
    Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2.
    Ursing C; Wikner J; Brismar K; Röjdmark S
    J Endocrinol Invest; 2003 May; 26(5):403-6. PubMed ID: 12906366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.
    Christensen M; Andersson K; Dalén P; Mirghani RA; Muirhead GJ; Nordmark A; Tybring G; Wahlberg A; Yaşar U; Bertilsson L
    Clin Pharmacol Ther; 2003 Jun; 73(6):517-28. PubMed ID: 12811361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
    Benowitz NL; Peng M; Jacob P
    Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New specific marker of cytochrome P450 1A2 activity.
    Filimonova AA; Ziganshina LE; Ziganshin AU; Chichirov AA
    Bull Exp Biol Med; 2011 Apr; 150(6):762-4. PubMed ID: 22235437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
    Backman JT; Karjalainen MJ; Neuvonen M; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2006 Sep; 62(3):345-57. PubMed ID: 16934051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.
    Saruwatari J; Nakagawa K; Shindo J; Nachi S; Echizen H; Ishizaki T
    J Pharm Pharmacol; 2003 Nov; 55(11):1553-9. PubMed ID: 14713367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.
    Kennedy MJ; Scripture CD; Kashuba AD; Scott CS; Gaedigk A; Kearns GL
    Clin Pharmacol Ther; 2004 Mar; 75(3):163-71. PubMed ID: 15001967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advance in cytochrome P450 1A2].
    Xiao P; Zhou HH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):456-60. PubMed ID: 18544853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why dried blood spots are an ideal tool for CYP1A2 phenotyping.
    De Kesel PM; Lambert WE; Stove CP
    Clin Pharmacokinet; 2014 Aug; 53(8):763-71. PubMed ID: 24980692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.